Importance of dual induction tests for coronary vasospasm and ventricular fibrillation in patients surviving out-of-hospital cardiac arrest

Circulation Journal

Volumn 73, Issue 4, 2009, Pages 767-769

  Takagi, Yusuke ^a   Yasuda, Satoshi ^a   Takahashi, Jun ^a   Takeda, Morihiko ^a   Nakayama, Masaharu ^a   Ito, Kenta ^a   Hirose, Masanori ^a   Wakayama, Yuji ^a   Fukuda, Koji ^a   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary vasospasm; Electrophysiology; Sudden cardiac death

Indexed keywords

ACETYLCHOLINE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY SPASM; DEFIBRILLATOR; FEMALE; HEART ARREST; HEART ELECTROPHYSIOLOGY; HEART STIMULATION; HEART VENTRICLE FIBRILLATION; HUMAN; LABORATORY TEST; MALE; MEDICAL DOCUMENTATION; OUTPATIENT DEPARTMENT; PREVALENCE; PROVOCATION TEST; SURVIVAL RATE;

ADULT; CORONARY VASOSPASM; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART ARREST; HOSPITALS; HUMANS; MALE; MIDDLE AGED; SURVIVAL RATE; VENTRICULAR FIBRILLATION;

EID: 65649111174     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0061     Document Type: Article

References (10)

1. Nishiuchi T, Hayashino Y, Fukuhara S, Iwami T, Hayashi Y, Hiraide A, et al. Survival rate and factors associated with 1-month survival of witnessed out-of-hospital cardiac arrest of cardiac origin with ventricular fibrillation and pulseless ventricular tachycardia: The Utstein Osaka project. Resuscitation 2008; 78: 307-313.
2. Böttiger BW, Arntz HR, Chamberlain DA, Bluhmki E, Belmans A, Danays T, et al; TROICA Trial Investigators; European Resuscitation Council Study Group: Thrombolysis during resuscitation for out-of-hospital cardiac arrest. N Engl J Med 2008; 359: 2651-2662.
3. Tester DJ, Ackerman MJ. The role of molecular autopsy in unexplained sudden cardiac death. Curr Opin Cardiol 2006; 21: 166-172. (Pubitemid 44315078)
4. Honda T, Sugiyama S, Sakamoto T, Kaikita K, Ogawa H. Impact of delta-sarcoglycan gene polymorphism on the occurrence of coronary spastic angina in Japanese patients with hypertrophic cardiomyopathy. Circ J 2007; 71: 1263-1267. (Pubitemid 47195344)
5. Akasaka T, Yoshida K, Hozumi T, Takagi T, Kawamoto T, Kaji S, et al. Comparison of coronary flow reserve between focal and diffuse vasoconstriction induced by ergonovine in patients with vasospastic angina. Am J Cardiol 1997; 80: 705-710. (Pubitemid 27413576)
6. + channel-blocker pilsicainide on the ST-segment response in the right precordial leads in patients with normal left ventricular function. Circ J 2007; 71: 57-62.
7. American College of Cardiology/American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation 2006; 114: e385-e484.
8. Meisel SR, Mazur A, Chetboun I, Epshtein M, Canetti M, Gallimidi J, et al. Usefulness of implantable cardioverter-defibrillators in refractory variant angina pectoris complicated by ventricular fibrillation in patients with angiographically normal coronary arteries. Am J Cardiol 2002; 89: 1114-1116. (Pubitemid 34462859)
9. Myerburg RJ, Kessler KM, Mallon SM, Cox MM, deMarchena E, Interian A Jr, et al. Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm. N Engl J Med 1992; 326: 1451-1455.
10. Yasue H, Mizuno Y, Harada E, Itoh T, Nakagawa H, Nakayama M, et al. SCAST (Statin and Coronary Artery Spasm Trial) Investigators: Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. J Am Coll Cardiol 2008; 51: 1742-1748.